Vascular Access in Oncology Patients

被引:189
作者
Gallieni, Maurizio [1 ,2 ]
Pittiruti, Mauro [3 ,4 ]
Biffi, Roberto [5 ]
机构
[1] Univ Milan, Sch Med, I-20122 Milan, Italy
[2] San Paolo Hosp, Renal Unit, Milan, Italy
[3] Univ Cattolica Sacro Cuore, Italian Natl Res Council, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Dept Surg, Rome, Italy
[5] European Inst Oncol, Div Abdomino Pelv Surg, Milan, Italy
关键词
D O I
10.3322/CA.2008.0015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adequate vascular access is of paramount importance in oncology patients. It is important in the initial phase of surgical treatment or chemotherapy, as well as in the chronic management of advanced cancer and in the palliative care setting. We present an overview of the available vascular access devices and of the most relevant issues regarding insertion and management of vascular access, Particular emphasis is given to the use of ultrasound guidance as the preferred technique of insertion, which has dramatically decreased insertion-related complications. Vascular access management has considerably improved after the publication of effective guidelines for the appropriate nursing of the vascular device, which has reduced the risk of late complications, such as catheter-related bloodstream infection. However, many areas of clinical practice are still lacking an evidence-based background, such as the choice of the most appropriate vascular access device in each clinical situation, as well as prevention and treatment of thrombosis. We suggest an approach to the choice of the most appropriate vascular access device for the oncology patient, based on the literature available to date. (CA Cancer J Clin 2008;58:323-346.) (C) American Cancer Society, Inc., 2008.
引用
收藏
页码:323 / 346
页数:24
相关论文
共 111 条
  • [1] Therapy Insight: venous-catheter-related thrombosis in cancer patients
    Agnelli, G
    Verso, M
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (04): : 214 - 222
  • [2] [Anonymous], 2001, Am J Kidney Dis, V37, pS137
  • [3] A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients
    Araujo, C.
    Silva, J. P.
    Antunes, P.
    Fernandes, J. M.
    Dias, C.
    Pereira, H.
    Dias, T.
    Fougo, J. L.
    [J]. EJSO, 2008, 34 (02): : 222 - 226
  • [4] Arch Penelope, 2007, Clin J Oncol Nurs, V11, P485, DOI 10.1188/07.CJON.485-488
  • [5] Improving patient outcomes through CQI: Vascular access planning
    Barton, AJ
    Danek, G
    Johns, P
    Coons, M
    [J]. JOURNAL OF NURSING CARE QUALITY, 1998, 13 (02) : 77 - 85
  • [6] Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients
    Biffi, R
    Pozzi, S
    Agazzi, A
    Pace, U
    Floridi, A
    Cenciarelli, S
    Peveri, V
    Cocqui, A
    Andreoni, B
    Martinelli, G
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (02) : 296 - 300
  • [7] Totally implantable central venous access ports for long-term chemotherapy - A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days
    Biffi, R
    de Braud, E
    Orsi, E
    Pozzi, S
    Mauri, S
    Goldhirsch, A
    Nole, F
    Andreoni, B
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (07) : 767 - 773
  • [8] Biffi R, 2001, CANCER, V92, P1204, DOI 10.1002/1097-0142(20010901)92:5<1204::AID-CNCR1439>3.0.CO
  • [9] 2-9
  • [10] Guidelines on the insertion and management of central venous access devices in adults
    Bishop, L.
    Dougherty, L.
    Bodenham, A.
    Mansi, J.
    Crowe, P.
    Kibbler, C.
    Shannon, M.
    Treleaven, J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 (04) : 261 - 278